logo

Indian News

Share SHARE

pharma-121517.jpg Clinical trials are major catalysts for biotech/pharma companies as positive study data can boost the stock price while unfavorable results can send the stocks plummeting.

asianmarketlow-121517.jpg Asian markets ended mostly weak on Friday, with uncertainty about the outlook for the Republican tax reform plan weighing on investor sentiment.

Marinus-Pharma-121517.jpg 2017 has been an exceptional year for Marinus Pharmaceuticals Inc. (MRNS) as the stock is up an impressive 823% year-to-date, way ahead of the iShares NASDAQ Biotechnology Index (IBB), which has returned just 18% during the same time frame.

Dec14-up-141217.jpg Here's what is making news at GHDX, ARGX and RMTI.

Dec13-up-121317.jpg The following are some of today's top gainers in the pharma/biotech sector.

Pharma-121317.jpg Today's Daily Dose brings you news about Aduro's revised pipeline; FDA approval of a new indication for CoolSculpting; Blueprint's stock offering; encouraging preliminary results from Cellectis' CALM and PALL trials; expanded FDA approval for GlaxoSmithKline's Nucala and Omeros' OMIDRIA.

Follow RTT